These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9794932)

  • 1. Interferon-induced thrombocytopenia: is it time for thrombopoietin.
    Martin TG; Shuman MA
    Hepatology; 1998 Nov; 28(5):1430-2. PubMed ID: 9794932
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-induced "lupoid" thrombocytopenia in chronic hepatitis C.
    Tappero G; Guerrasio A; Gallo M; Negro F; Hadengue A; Angeli A
    J Hepatol; 1996 Jan; 24(1):124. PubMed ID: 8834037
    [No Abstract]   [Full Text] [Related]  

  • 3. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
    Goldberg J
    Curr Opin Mol Ther; 2000 Apr; 2(2):211-5. PubMed ID: 11249644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab.
    Weitz IC
    Am J Hematol; 2005 Feb; 78(2):138-41. PubMed ID: 15682410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
    Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin: platelets on demand?
    Kaushansky K
    Ann Intern Med; 1997 May; 126(9):731-3. PubMed ID: 9139560
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical results with MGDF].
    Martín G
    Sangre (Barc); 1997 Apr; 42 Suppl 1():61. PubMed ID: 9381307
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombopoietin: it has been cloned, therefore, it exists!
    Gupta P
    Natl Med J India; 1998; 11(2):80-1. PubMed ID: 9624867
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombopoietin--clinically realized?
    Levin J
    N Engl J Med; 1997 Feb; 336(6):434-6. PubMed ID: 9010152
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon.
    Greenway HT
    West J Med; 1994 Apr; 160(4):363. PubMed ID: 7517599
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recombinant blood hormones in clinical practice].
    von dem Borne AE
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2068-72. PubMed ID: 2446154
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
    Vadhan-Raj S; Patel S; Bueso-Ramos C; Folloder J; Papadopolous N; Burgess A; Broemeling LD; Broxmeyer HE; Benjamin RS
    J Clin Oncol; 2003 Aug; 21(16):3158-67. PubMed ID: 12915607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia.
    Sohara N; Takagi H; Kakizaki S; Sato K; Mori M
    Transpl Int; 2006 Mar; 19(3):255-7. PubMed ID: 16441778
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
    Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F
    J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of hematopoietic factors in thrombocytopenia].
    Oda A
    Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1143-8. PubMed ID: 10892191
    [No Abstract]   [Full Text] [Related]  

  • 18. [Splenectomy before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia].
    Aizawa N; Nishiguchi S
    Nihon Rinsho; 2011 May; 69 Suppl 4():201-5. PubMed ID: 22096919
    [No Abstract]   [Full Text] [Related]  

  • 19. The interferon system in acute and chronic viral hepatitis.
    Peters M; Davis GL; Dooley JS; Hoofnagle JH
    Prog Liver Dis; 1986; 8():453-67. PubMed ID: 2424048
    [No Abstract]   [Full Text] [Related]  

  • 20. Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostine.
    Budd GT; Ganapathi R; Wood L; Snyder J; McLain D; Bukowski RM
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):41-50. PubMed ID: 10348260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.